Upexi (UPXI), a Nasdaq-listed cryptocurrency treasury firm specializing in Solana , has submitted a filing to raise up to $1 billion in a shelf registration with the U.S. Securities and Exchange Commission (SEC).
This action allows the company to raise capital by selling common stock, preferred shares, debt instruments, warrants, or units in multiple offerings over time.
Headquartered in Tampa, Florida, Upexi oversees several consumer brands, including Cure Mushrooms medicinal products and Lucky Tail pet care. It also holds the fourth-largest SOL treasury among public companies, with over 2 million tokens ($248 million) on its balance sheet.
Funds generated from these securities sales, if carried out, may be allocated for working capital, research and development, acquisitions, debt repayment, and other general purposes.
The company’s stock price declined nearly 7% on Tuesday to $1.85. Year-to-date, UPXI has lost about 50% of its market value, while SOL has decreased by 34%.
